<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JDM</journal-id><journal-title-group><journal-title>Journal of Diabetes Mellitus</journal-title></journal-title-group><issn pub-type="epub">2160-5831</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jdm.2016.62015</article-id><article-id pub-id-type="publisher-id">JDM-66259</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  The Relationship between Central Retinal Artery Resistive Index and Measures of Renal Function in Type 2 Diabetes
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>.</surname><given-names>O. Ayoola</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>D.</surname><given-names>O. Soyoye</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>S.</surname><given-names>D. Dawha</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>R.</surname><given-names>T. Ikem</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>O.</surname><given-names>H. Onakpoya</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>T.</surname><given-names>A. Adedeji</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>F.</surname><given-names>A. Arogundade</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>Department of Chemical Pathology, Obafemi Awolowo University, Ile-Ife, Nigeria</addr-line></aff><aff id="aff2"><addr-line>Department of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria</addr-line></aff><aff id="aff3"><addr-line>Department of Ophthalmology, Obafemi Awolowo University, Ile-Ife, Nigeria</addr-line></aff><aff id="aff1"><addr-line>Department of Radiology, Obafemi Awolowo University, Ile-Ife, Nigeria</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>oluyoola@gmail.com(.OA)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>03</month><year>2016</year></pub-date><volume>06</volume><issue>02</issue><fpage>146</fpage><lpage>151</lpage><history><date date-type="received"><day>10</day>	<month>February</month>	<year>2016</year></date><date date-type="rev-recd"><day>accepted</day>	<month>3</month>	<year>May</year>	</date><date date-type="accepted"><day>6</day>	<month>May</month>	<year>2016</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Renal and ocular vessels are some of the major vessels affected in patients with diabetes, and the involvement of these vessels is independent risk factors for other complications. Hemodynamic flow in arteries may be assessed by using measures such as resistive index, which is a non-invasive measure of the resistance in vessels. The association between retinopathy and nephropathy has been conflicting. This study assessed the relationship between resistive index of the central retinal artery and indices of nephropathy in type 2 diabetes. Method: This cross-sectional study examined 74 Nigerian diabetics who were selected consecutively from the out-patient diabetic clinic of a tertiary hospital in South-West Nigeria. Doppler ultrasound was used to determine the resistive index of the central retinal artery along with the right renal artery. The urinary and serum biochemical parameters were also done to determine the urinary albumin excretion and the glomerular filtration rate. Results: The mean age of participants was 59.62 &#177; 9.55 years. The mean central retinal artery resistive index (CRARI) was 0.77 &#177; 0.06, with 65 (87.8%) of the participants having elevated CRARI. There was no statistical difference between patients with normal CRARI and elevated CRARI in respect of their urinary albumin excretion (p = 0.796). There was no significant correlation between CRARI and estimated glomerular filtration rate (r = 0.120; p = 0.309) and right renal artery resistive index (r = 0.068; p = 0.564). Conclusion: This study demonstrates that central retinal artery resistive index (CRARI) may not be a predictor of renal function in diabetics.
 
</p></abstract><kwd-group><kwd>Ultrasound</kwd><kwd> Retinal Artery</kwd><kwd> Renal Function</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Diabetes is a metabolic disorder with multi-systemic affectation. Most of the complications of diabetes arise as a result of its effects on both macrovascular and microvascular vessels. Involvement of the ocular and renal microvessels may result in diabetic retinopathy and nephropathy respectively with attendant disability, economic burden and death. If diagnosed early, complications resulting from involvement of these vessels could be preventable, thereby reducing other cardiovascular events [<xref ref-type="bibr" rid="scirp.66259-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.66259-ref2">2</xref>] . In a review of results from the Nigeria national blindness and visual impairment survey, prevalence of diabetic retinopathy was 20.5% [<xref ref-type="bibr" rid="scirp.66259-ref3">3</xref>] . Rotimi et al. [<xref ref-type="bibr" rid="scirp.66259-ref4">4</xref>] reported a diabetic retinopathy prevalence of 17.3% among cohorts of diabetic patients in Nigeria. Prevalence of diabetic retinopathy has been reported to be between 16% and 55% in Africa [<xref ref-type="bibr" rid="scirp.66259-ref5">5</xref>] . Prevalence of microalbuminuria as a measure of diabetic nephropathy has been reported to be between 10% and 57% in Africans with type 2 diabetes [<xref ref-type="bibr" rid="scirp.66259-ref5">5</xref>] .</p><p>There have been reports of association between diabetic retinopathy and measures of nephropathy [<xref ref-type="bibr" rid="scirp.66259-ref6">6</xref>] - [<xref ref-type="bibr" rid="scirp.66259-ref8">8</xref>] . Prakash et al., however, noted that diabetic retinopathy does not predict diabetic nephropathy in type 2 patients [<xref ref-type="bibr" rid="scirp.66259-ref9">9</xref>] . The association between ocular vascular resistance using resistive index and measures of chronic kidney disease and/or renal vascular resistance has been examined previously [<xref ref-type="bibr" rid="scirp.66259-ref10">10</xref>] . The usefulness of measurement of ocular resistive index as a measure of vascular resistance is not fully understood [<xref ref-type="bibr" rid="scirp.66259-ref11">11</xref>] . However, ocular vascular evaluations may be an accessible measure for early detection of both retinal and renal dysfunctions. Ultrasonography is a non-invasive, relatively inexpensive and readily available investigation. This study determined the relationship between central retinal artery resistive index (CRARI) and right renal artery resistive index (RRARI) and measures of nephropathy (albuminuria, glomerular filtration rates) in type 2 diabetes patients.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>This cross-sectional study involved consecutive patients with Type 2 Diabetes Mellitus recruited from the Diabetes clinic from June 2012 to May 2013. The Diabetes clinic is an out-patient clinic in the hospital premises that operates weekly with patients’ attendance of 100 - 120 people per clinic day. Ethical approval was granted by the Ethics and Research committee of the institution. Informed consent was sought and granted by all the participants. Participants with glaucoma and other conditions like ocular injury and conjunctivitis that could make Doppler assessment of the central retinal artery difficult were excluded by the Opthalmologist. Participants with recent febrile illness and other acute medical conditions were also excluded. Relevant history was taken and clinical examination done. Blood samples were taken to determine the serum fasting plasma glucose, total cholesterol, low-density lipoprotein, high-density lipoprotein, triglycerides, serum creatinine. Urinary albumin-creatinine ratio (UACR) of a random spot urine was determined using CLINITEK microalbumin (Siemens Healthcare Inc, Camberly, UK), a semi-quantitative strip test. UACR was calculated as albumin (&#181;g)/ creatinine(g). Normoalbuminuria, microalbuminuria and macroalbuminuria was defined using UACR of &lt;30 &#181;g/mg, 30 - 300 &#181;g/mg and &gt;300 &#181;g/mg respectively [<xref ref-type="bibr" rid="scirp.66259-ref12">12</xref>] . Estimated glomerular filtration rate (eGFR) was calculated using the Cockroft-Gault formula [<xref ref-type="bibr" rid="scirp.66259-ref13">13</xref>] and this was used to stage kidney function into stage 1 (≥90 mls/min); stage 2 (60 - 89 mls/min); stage 3 (30 - 59 mls/min); stage 4 (15 - 29 mls/min); stage 5 (&lt;15 mls/min). The formula is as follows:</p><disp-formula id="scirp.66259-formula231"><graphic  xlink:href="http://html.scirp.org/file/4-4300352x7.png"  xlink:type="simple"/></disp-formula><p>The value obtained is multiplied by 0.85 in women.</p><p>C<sub>cr</sub> = Creatinine clearance; S<sub>cr</sub> = Serum creatinine (mg/dL)</p><p>Doppler ultrasound scan of the right central retinal and right renal arteries was done using a Mindray DC-7 ultrasound machine and the resistive indices of the vessels calculated from the formula [<xref ref-type="bibr" rid="scirp.66259-ref11">11</xref>] :</p><disp-formula id="scirp.66259-formula232"><graphic  xlink:href="http://html.scirp.org/file/4-4300352x8.png"  xlink:type="simple"/></disp-formula><p>where PSV = Peak systolic flow velocity; EDV = End-diastolic flow velocity.</p><p>Resistive index of &gt;0.70 was considered elevated [<xref ref-type="bibr" rid="scirp.66259-ref10">10</xref>] . Data was inputted into a personal computer and analysed using the statistical software package SPSS version 20 (IBM Corp Released 2011. IBM SPSS Statistics for Windows, Version 20.0, Armonk, NY). Significant differences between continuous variables were assessed using Student’s t test, while chi square test (χ<sup>2</sup>) was used to determine differences between categorical variables. Correlation analysis was done to determine the relationship between central retinal resistive index and other metric variables. p value of &lt;0.05 was taken to be statistically significant.</p></sec><sec id="s3"><title>3. Results</title><p>Seventy-four type 2 diabetic patients consisting of 32 males and 42 females. Mean age of study population was 59.62 &#177; 9.55 years (male: 59.66 &#177; 9.57 vs female: 59.60 &#177; 9.65; p = 0.978). <xref ref-type="table" rid="table1">Table 1</xref> shows the clinical and laboratory parameters in the study population.</p><p>Sixty five (87.8%) participants had elevated CRARI, with more females 36 (55.4%) having elevated CRARI compared with males 29 (44.6%) (p = 0.723). Mean CRARI in the study participants was 0.77 &#177; 0.06 (male: 0.77 &#177; 0.05; female: 0.78 &#177; 0.07, p = 0.430). Of the participants with elevated CRARI, 9 (13.8%), 29 (44.6%) and 27 (41.6%) had macroalbuminuria, microalbuminuria and normoalbuminuria respectively (p = 0.159). <xref ref-type="table" rid="table2">Table 2</xref> shows the differences between participants with normal CRARI and those with elevated CRARI.</p><p>Eleven (14.9%) participants had macroalbuminuria (male―4 (5.4%) vs female―7(9.5%); and 30 (40.5%) had microalbuminuria (male―12 (16.2%) vs female―18 (24.3%) (p = 0.701). <xref ref-type="fig" rid="fig1">Figure 1</xref> shows the relationship between central retinal artery resistive index and stages of chronic kidney disease among participants.</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> A clustered bar chart showing a frequency distribution based on CRARI normalcy and stages of chronic kidney disease using the Cockroft gault equation among study participants. X<sup>2</sup> = 1.674; df = 4; p = 0.796</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/4-4300352x9.png"/></fig><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> A table showing the clinical and laboratory parameters among study participants by gender</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Characteristic</th><th align="center" valign="middle" >Male (mean &#177; SD) N = 32</th><th align="center" valign="middle" >Female (mean &#177; SD) N = 4</th><th align="center" valign="middle" >p value</th></tr></thead><tr><td align="center" valign="middle" >Duration of diabetes (years)</td><td align="center" valign="middle" >8.76 &#177; 6.72</td><td align="center" valign="middle" >8.08 &#177; 6.90</td><td align="center" valign="middle" >0.665</td></tr><tr><td align="center" valign="middle" >Body mass index (kg/m<sup>2</sup>)</td><td align="center" valign="middle" >25.72 &#177; 4.27</td><td align="center" valign="middle" >28.76 &#177; 5.79</td><td align="center" valign="middle" >0.011</td></tr><tr><td align="center" valign="middle" >SBP (mmHg)</td><td align="center" valign="middle" >132.19 &#177; 17.22</td><td align="center" valign="middle" >130.64 &#177; 19.58</td><td align="center" valign="middle" >0.720</td></tr><tr><td align="center" valign="middle" >DBP (mmHg)</td><td align="center" valign="middle" >77.38 &#177; 9.19</td><td align="center" valign="middle" >76.38 &#177; 9.34</td><td align="center" valign="middle" >0.649</td></tr><tr><td align="center" valign="middle" >eGFR (mls/min)</td><td align="center" valign="middle" >88.17 &#177; 48.68</td><td align="center" valign="middle" >72.20 &#177; 30.86</td><td align="center" valign="middle" >0.461</td></tr><tr><td align="center" valign="middle" >FPG (mmol/L)</td><td align="center" valign="middle" >7.44 &#177; 1.85</td><td align="center" valign="middle" >7.44 &#177; 1.78</td><td align="center" valign="middle" >0.976</td></tr><tr><td align="center" valign="middle" >TC (mmol/L)</td><td align="center" valign="middle" >4.12 &#177; 1.00</td><td align="center" valign="middle" >4.34 &#177; 0.97</td><td align="center" valign="middle" >0.411</td></tr><tr><td align="center" valign="middle" >HDL (mmol/L)</td><td align="center" valign="middle" >1.23 &#177; 0.52</td><td align="center" valign="middle" >1.21 &#177; 0.57</td><td align="center" valign="middle" >0.818</td></tr><tr><td align="center" valign="middle" >TG (mmol/L)</td><td align="center" valign="middle" >1.31 &#177; 1.07</td><td align="center" valign="middle" >1.07 &#177; 0.41</td><td align="center" valign="middle" >0.132</td></tr><tr><td align="center" valign="middle" >LDL (mmol/L)</td><td align="center" valign="middle" >2.44 &#177; 1.13</td><td align="center" valign="middle" >2.62 &#177; 0.79</td><td align="center" valign="middle" >0.478</td></tr><tr><td align="center" valign="middle" >RRARI</td><td align="center" valign="middle" >0.72 &#177; 0.06</td><td align="center" valign="middle" >0.73 &#177; 0.07</td><td align="center" valign="middle" >0.698</td></tr></tbody></table></table-wrap><p>SPB―Systolic blood pressure; DBP―Diastolic blood pressure; eGFR―estimated glomerular filtration rate; FPG―Fasting plasma glucose; TC― Total cholesterol; HDL―high density lipoprotein; TG―Triglycerides; LDL―Low density lipoprotein; RRARI―right renal artery resistive index.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> A table showing a comparison of mean values of demographic, clinical and biochemical parameters in participants with normal and elevated central retinal artery resistive index</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Parameter</th><th align="center" valign="middle" >Normal CRARI (N = 9)</th><th align="center" valign="middle" >Elevated CRARI (N = 65)</th><th align="center" valign="middle" >p value</th></tr></thead><tr><td align="center" valign="middle" >Age (years)</td><td align="center" valign="middle" >60.22 &#177;11.04</td><td align="center" valign="middle" >59.54 &#177; 9.41</td><td align="center" valign="middle" >0.863</td></tr><tr><td align="center" valign="middle" >Body mass index (kg/m<sup>2</sup>)</td><td align="center" valign="middle" >29.91 &#177; 4.19</td><td align="center" valign="middle" >27.11 &#177; 5.46</td><td align="center" valign="middle" >0.096</td></tr><tr><td align="center" valign="middle" >Systolic BP (mmHg)</td><td align="center" valign="middle" >130.89 &#177;20.42</td><td align="center" valign="middle" >131.37 &#177; 18.38</td><td align="center" valign="middle" >0.948</td></tr><tr><td align="center" valign="middle" >Diastolic BP (mmHg)</td><td align="center" valign="middle" >77.89 &#177; 4.54</td><td align="center" valign="middle" >76.66 &#177; 9.71</td><td align="center" valign="middle" >0.533</td></tr><tr><td align="center" valign="middle" >eGFR (ml/min/1.73m<sup>2</sup>)</td><td align="center" valign="middle" >67.24 &#177; 31.01</td><td align="center" valign="middle" >80.75 &#177; 41.08</td><td align="center" valign="middle" >0.263</td></tr><tr><td align="center" valign="middle" >FBS (mmol/L)</td><td align="center" valign="middle" >6.83 &#177;1.09</td><td align="center" valign="middle" >7.53 &#177; 1.87</td><td align="center" valign="middle" >0.126</td></tr><tr><td align="center" valign="middle" >TC (mmol/L)</td><td align="center" valign="middle" >3.92 &#177; 1.23</td><td align="center" valign="middle" >4.30 &#177; 0.95</td><td align="center" valign="middle" >0.425</td></tr><tr><td align="center" valign="middle" >HDL (mmol/L)</td><td align="center" valign="middle" >1.19 &#177; 0.73</td><td align="center" valign="middle" >1.22 &#177; 0.52</td><td align="center" valign="middle" >0.910</td></tr><tr><td align="center" valign="middle" >TG (mmol/L)</td><td align="center" valign="middle" >1.54 &#177; 1.68</td><td align="center" valign="middle" >1.07 &#177; 0.57</td><td align="center" valign="middle" >0.451</td></tr><tr><td align="center" valign="middle" >LDL (mmol/L)</td><td align="center" valign="middle" >2.23 &#177; 0.76</td><td align="center" valign="middle" >2.56 &#177; 0.97</td><td align="center" valign="middle" >0.494</td></tr><tr><td align="center" valign="middle" >RRARI</td><td align="center" valign="middle" >0.73 &#177; 0.09</td><td align="center" valign="middle" >0.72 &#177; 0.06</td><td align="center" valign="middle" >0.090</td></tr></tbody></table></table-wrap><p>SPB―Systolic blood pressure; DBP―Diastolic blood pressure; eGFR―estimated glomerular filtration rate; FPG―Fasting plasma glucose; TC― Total cholesterol; HDL―high density lipoprotein; TG―Triglycerides; LDL―Low density lipoprotein; RRARI―right renal artery resistive index.</p><p>There was no significant correlation between CRARI and eGFR (r = 0.120; p = 0.309),duration of diabetes (r = −0.081, p = 494), body mass index (r = −0.017; p = 0.884), systolic blood pressure (r = 0.027; p = 0.819), fasting plasma glucose (r = −0.112; p = 342), total cholesterol (r = −0.003; p = 0.978), serum high-density lipoprotein (r = −0.162; p = 0.169), serum triglycerides ( r = −0.046; p = 0.710), serum low-density lipoprotein (r = 0.027; p = 0.836) or RRARI (r = 0.068; p = 0.564).</p></sec><sec id="s4"><title>4. Discussion</title><p>Hyperglycemia selectively damages the endothelial cells of the retina, glomerulus and neurons, with shared pathologic characteristics in the development of these diabetic complications [<xref ref-type="bibr" rid="scirp.66259-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.66259-ref15">15</xref>] . Sustained hyperglycemia results in polyol accumulation, formation of advanced glycation end products (AGEs), oxidative stress, and activation of protein kinase C (PKC), which are pathway postulated to be responsible for microvascular complications in diabetes [<xref ref-type="bibr" rid="scirp.66259-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.66259-ref16">16</xref>] . Resistive index assessment in the central retinal artery is a measure of increased resistance in this vessel, which is suggested to contribute to diabetic retinopathy. Assessment of central retinal artery resistive index may be an early marker of overt diabetic retinopathy [<xref ref-type="bibr" rid="scirp.66259-ref17">17</xref>] .</p><p>In this study, mean central retinal artery resistive index was 0.77 &#177; 0.06. This is similar to that obtained by Amin et al. [<xref ref-type="bibr" rid="scirp.66259-ref2">2</xref>] , who reported mean CRARI of 0.75 &#177; 0.04 in patients with type 2 diabetes without retinopathy, which was significantly higher compared with controls. Most of the patients with elevated CRARI were in the early stages of chronic kidney disease. Mean systolic blood pressure, estimated glomerular filtration rate, fasting blood glucose, total cholesterol, high density lipoprotein and low-density lipoprotein were higher in patients with elevated CRARI compared with patients with normal CRARI, but values were not statistically significant (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>This study was conducted to ascertain the association between resistive index of the right central retinal artery and measures of renal function, for a possible early detection of renal microvascular involvement in diabetes. There was no correlation between central retinal artery resistive index and glomerular filtration rate and resistive index of the right renal artery.</p><p>Resistive index has been regarded as a measure of vascular resistance; however some studies [<xref ref-type="bibr" rid="scirp.66259-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.66259-ref19">19</xref>] have suggested that resistive index is not only a measure of vascular resistance, but of impedance, which is a measure of both vascular resistance and vascular compliance. Vascular compliance, defined as change in vascular volume with change in vascular pressure [<xref ref-type="bibr" rid="scirp.66259-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.66259-ref18">18</xref>] , has profound individual variability even when the vascular resistance is constant [<xref ref-type="bibr" rid="scirp.66259-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.66259-ref19">19</xref>] . In effect, the resistive index would vary depending on the compliance of the vessel. This variability may explain the lack of association between central retinal artery resistive index and the measures of renal function studied. Our finding may also suggest that the pathogenic mechanism for resistance in the ocular vessels may be different from that responsible for nephropathy in patients with type 2 diabetes mellitus.</p><p>It is acknowledged that estimation of urinary protein excretion over a 24-hr period is the gold standard method due to a high degree of variation in the urinary protein concentration during the course of the day [<xref ref-type="bibr" rid="scirp.66259-ref20">20</xref>] ; this approach however would have been impractical to undertake as it would have been impracticable for the greater majority of subjects recruited for the study. Nevertheless statistically significant values with correlations as high as 0.98 [<xref ref-type="bibr" rid="scirp.66259-ref21">21</xref>] have been reported for ratio of protein: creatinine on a spot urine sample with 24-hr urine collection sample.</p></sec><sec id="s5"><title>5. Conclusions</title><p>The small size of our study may limit its interpretation to the general population. Glycated hemoglobin, a long term measurement of glycemia was not measured in our participants. Despite these limitations, this study is crucial in recognizing the lack of association between measure of resistance of ocular vessels and measures of stages of renal dysfunction. Additionally, to the best of our knowledge, this is the first study that considers the possible association between resistive index in ocular vessels (using the central retinal artery) and diabetic nephropathy in Nigerians. Future studies should be considered in apparently healthy population.</p><p>This study found no relationship between central retinal artery resistive index and glomerular filtration rate, urinary albumin excretion and resistive index of the right renal artery.</p></sec><sec id="s6"><title>Cite this paper</title><p>O. O. Ayoola,D. O. Soyoye,S. D. Dawha,R. T. Ikem,O. H. Onakpoya,T. A. Adedeji,F. A. Arogundade, (2016) The Relationship between Central Retinal Artery Resistive Index and Measures of Renal Function in Type 2 Diabetes. Journal of Diabetes Mellitus,06,146-151. doi: 10.4236/jdm.2016.62015</p></sec><sec id="s7"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.66259-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">James, M.T., Hemmelgarn, B.R. and Tonelli, M. (2010) Early Recognition and Prevention of Chronic Kidney Disease. The Lancet, 375, 1296-1309. http://dx.doi.org/10.1016/S0140-6736(09)62004-3</mixed-citation></ref><ref id="scirp.66259-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Amin, M.B., Rekha, K.P., Shegufta, F., Rahman, M.T., Abedin, N. and Mohuiddin, A.S. (2014) Resistive Index of Retinal Arterial Blood Flow in Type-II Diabetics without Retinopathy. Bangladesh Medical Journal Khulna, 47, 7-11.</mixed-citation></ref><ref id="scirp.66259-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Kyari, F., Tafida, A., Sivasubramaniam, S., Murthy, G.V., Peto, T. and Gilbert, C.E. (2014) Prevalence and Risk Factors for Diabetes and Diabetic Retinopathy: Results from the Nigeria National Blindness and Visual Impairment Survey. BMC Public Health, 14, 1299. http://dx.doi.org/10.1186/1471-2458-14-1299</mixed-citation></ref><ref id="scirp.66259-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Rotimi, C., Daniel, H., Zhou, J., Obisesan, A., Chen, G. and Chen, Y. (2003) Prevalence and Determinants of Diabetic Retinopathy and Cataracts in West African Type 2 Diabetes Patients. Ethnicity and Disease, 13, S2-S110.</mixed-citation></ref><ref id="scirp.66259-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Tesfaye, S. and Gill, G. (2001) Chronic Diabetic Complications in Africa. The African Journal of Diabetes Medicine, 19, 37-40.</mixed-citation></ref><ref id="scirp.66259-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Chandy, A., Pawar, B., John, M. and Isaac, R. (2008) Association between Diabetic Nephropathy and Other Diabetic Microvascular and Macrovascular Complications. Saudi Journal of Kidney Disease and Transplantation, 19, 924.</mixed-citation></ref><ref id="scirp.66259-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Grunwald, J.E., Alexander, J., Ying, G.S., Maguire, M., Daniel, E., Whittock-Martin, R. and Townsend, R. (2012) Retinopathy and Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort (CRIC) Study. Archives of Ophthalmology, 130, 1136-1144. http://dx.doi.org/10.1001/archophthalmol.2012.1800</mixed-citation></ref><ref id="scirp.66259-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Klein, R., Zinman, B., Gardiner, R., Suissa, S., Donnelly, S.M., Sinaiko, A.R., et al. (2005) The Relationship of Diabetic Retinopathy to Preclinical Diabetic Glomerulopathy Lesions in Type 1 Diabetic Patients. The Renin-Angiotensin System Study. Diabetes, 54, 527-533. http://dx.doi.org/10.2337/diabetes.54.2.527</mixed-citation></ref><ref id="scirp.66259-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Prakash, J., Lodha, M., Singh, S.K., Vohra, R. and Raja, R. (2007) Diabetic Retinopathy Is a Poor Predictor of Type of Nephropathy in Proteinuric Type 2 Diabetic Patients. The Journal of the Association of Physicians of India, 55, 412-416.</mixed-citation></ref><ref id="scirp.66259-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Basturk, T., Akcay, M., Albayrak, R., Unsal, A., Ulas, T. and Koc, Y. (2012) Correlation between the Resistive Index Values of Renal and Orbital Arteries. Kidney and Blood Pressure Research, 35, 332-339.http://dx.doi.org/10.1159/000336105</mixed-citation></ref><ref id="scirp.66259-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Polska, E., Kircher, K., Ehrlich, P., Vecsei, P.V. and Schmetterer, L. (2001) RI in Central Retinal Artery as Assessed by CDI Does Not Correspond to Retinal Vascular Resistance. American Journal of Physiology Heart and Circulatory Physiology, 280, H1442-H1447.</mixed-citation></ref><ref id="scirp.66259-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Hamano, K., Nitta, A., Ohtake, T. and Kobayashi, S. (2008) Associations of Renal Vascular Resistance with Albuminuria and Other Macroangiopathy in Type 2 Diabetic Patients. Diabetes Care, 31, 1853-1857.http://dx.doi.org/10.2337/dc08-0168</mixed-citation></ref><ref id="scirp.66259-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">National Kidney Foundation (2002) K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification.</mixed-citation></ref><ref id="scirp.66259-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Brownlee, M. (2005) The Pathobiology of Diabetic Complications: A Unifying Mechanism. Diabetes, 54, 1615-1625.http://dx.doi.org/10.2337/diabetes.54.6.1615</mixed-citation></ref><ref id="scirp.66259-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Melmed, S., Polonsky, K.S., Larsen, P.R. and Kronenberg, H.M. (2015) Williams Textbook of Endocrinology. Elsevier Health Sciences, Philadelphia.</mixed-citation></ref><ref id="scirp.66259-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Fong, D.S., Aiello, L.P., Gardner, T.W., King, G.L., Blankenship, G., Cavallerano, J.D. and Klein, R. (2004) Retinopathy in Diabetes. Diabetes Care, 27, S84-S87. http://dx.doi.org/10.2337/diacare.27.2007.s84</mixed-citation></ref><ref id="scirp.66259-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Arai, T., Numata, K., Tanaka, K., Kiba, T., Kawasaki, S., Saito, T. and Sekihara, H. (1998) Ocular Arterial Flow Hemodynamics in Patients with Diabetes Mellitus. Journal of Ultrasound in Medicine, 17, 675-681.</mixed-citation></ref><ref id="scirp.66259-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Bude, R.O. and Rubin, J.M. (1999) Relationship between the Resistive Index and Vascular Compliance and Resistance. Radiology, 211, 411-417. http://dx.doi.org/10.1148/radiology.211.2.r99ma48411</mixed-citation></ref><ref id="scirp.66259-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Saunders, H.M., Burns, P.N., Needleman, L., Liu, J., Boston, R., Wortman, J.A. and Chan, L. (1998) Hemodynamic Factors Affecting Uterine Artery Doppler Waveform Pulsability in Sheep. Journal of Ultrasound in Medicine, 17, 357-368.</mixed-citation></ref><ref id="scirp.66259-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Price, C.P., Newall, R.G. and Boyd, J.C. (2005) Use of Protein: Creatinine Ratio Measurements on Random Urine Samples for Prediction of Significant Proteinuria: A Systematic Review. Clinical Chemistry, 51, 1577-1586.http://dx.doi.org/10.1373/clinchem.2005.049742</mixed-citation></ref><ref id="scirp.66259-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Mitchell, S.C.M., Sheldon, T.A. and Shaw, A.B. (1993) Quantification of Proteinuria: A Re-Evaluation of the Protein/Creatinine Ratio for Elderly subjects. Age Ageing, 22, 443-449. http://dx.doi.org/10.1093/ageing/22.6.443</mixed-citation></ref></ref-list></back></article>